MIND MEDICINE (MINDMED)MIND MEDICINE (MINDMED)MIND MEDICINE (MINDMED)

MIND MEDICINE (MINDMED)

No trades
See on Supercharts
Market capitalization
‪574.62 M‬EUR
−2.220EUR
‪−86.73 M‬EUR
‪26.94 M‬
Beta (1Y)
2.53

About MIND MEDICINE (MINDMED)

CEO
Robert Barrow
Headquarters
New York
Website
Employees (FY)
57
Founded
2019
FIGI
BBG00FD7MXV5
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MIND MEDICINE (MINDMED) stocks are traded under the ticker MMQ.
MIND MEDICINE (MINDMED) is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
MMQ earnings for the last quarter are −0.43 EUR per share, whereas the estimation was −0.62 EUR resulting in a 31.22% surprise. The estimated earnings for the next quarter are −0.42 EUR per share. See more details about MIND MEDICINE (MINDMED) earnings.
Yes, you can track MIND MEDICINE (MINDMED) financials in yearly and quarterly reports right on TradingView.
MMQ net income for the last quarter is ‪−21.62 M‬ EUR, while the quarter before that showed ‪−16.96 M‬ EUR of net income which accounts for −27.52% change. Track more MIND MEDICINE (MINDMED) financial stats to get the full picture.
No, MMQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MMQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MIND MEDICINE (MINDMED) stock right from TradingView charts — choose your broker and connect to your account.
MMQ reached its all-time high on Apr 27, 2021 with the price of 75.000 EUR, and its all-time low was 1.960 EUR and was reached on Dec 29, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 57.00 employees. See our rating of the largest employees — is MIND MEDICINE (MINDMED) on this list?
We've gathered analysts' opinions on MIND MEDICINE (MINDMED) future price: according to them, MMQ price has a max estimate of 70.50 EUR and a min estimate of 15.04 EUR. Read a more detailed MIND MEDICINE (MINDMED) forecast: see what analysts think of MIND MEDICINE (MINDMED) and suggest that you do with its stocks.